Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-09-14

Clinical Trial Update: Otiprio Versus Ciprodex Tympanostomy Tube Outcomes [Phase 4]

View source ↗

Summary

Phase 4 trial comparing Otiprio to Ciprodex for tympanostomy tube outcomes was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ciprodex (ciprofloxacin/dexamethasone)
  • Otiprio (ciprofloxacin, dexamethasone? (note: Otiprio is ciprofloxacin otic suspension) )

Snippet

Sponsor: Boston Medical Center | Conditions: Otorrhea, Otitis Media With Effusion in Children | Phase 4 | Status: WITHDRAWN